Table 1 Distribution of cases and WSIs to training, validation and test set, as well as respective distributions of stains, IHC antibodies and scanner models.
From: A Multi-Stain Breast Cancer Histological Whole-Slide-Image Data Set from Routine Diagnostics
| Â | Training | Validation | Test | Total |
|---|---|---|---|---|
Cases | 750 (65.0%) | 100 (8.7%) | 303 (26.3%) | 1153 |
WSIs | 3406 (80.9%) | 200 (4.7%) | 606 (14.8%) | 4212 |
Stain and antibodies | ||||
H&E | 750 (22.0%) | 100 (50.0%) | 303 (50.0%) | 1153 (27.4%) |
ER | 732 (21.5%) | 29 (14.5%) | 84 (13.9%) | 845 (20.1%) |
KI67 | 732 (21.5%) | 29 (14.5%) | 82 (13.5%) | 843 (20.0%) |
PGR | 728 (21.4%) | 28 (14.0%) | 81 (13.4%) | 837 (19.9%) |
HER2 | 464 (13.6%) | 14 (7.0%) | 56 (9.2%) | 534 (12.7%) |
Scanners | ||||
NanoZoomer S360 | 559 (16.4%) | 38 (19.0%) | 205 (33.8%) | 802 (19.0%) |
NanoZoomer XR (1) | 884 (26.0%) | 46 (23.0%) | 203 (33.5%) | 1133 (26.9%) |
NanoZoomer XR (2) | 1963 (57.6%) | 116 (58.0%) | 198 (32.7%) | 2277 (54.1%) |
